Exam 4- Neuro, seizures, mental disorders, + depression Flashcards
seizure-def
brief episode abnorm electrical act in brain cells
can be recurrent (epilepsy)
cause seizures
largely idiopathic
genetic predispos.
2ndary causes- etoh withdrawl, dev defects, metabolic dis, fever (kids), birth injury, acquired neuro dis (tumor or inc icp), hypoglycemia
partial seizure
simple or complex
simple seizure
partcial
have awareness/memory and conciousness
20-60 seconds
complex seizures
partial consciousness impaired (stare/motionless) 45-90 sec.- longer
generalized seizure
no specific part of brain (affects both sides)
tonic- clonic or absence (disconnect from world- common in kids)
status epilepticus
constant convulsions
life threatening- med immergency
tonic-clonic- several min at close intervals
status epilepticus complications
hypotension, hypoxia, cardiac dysrhythmias
high-risk brain damage
status epilep- causes
abrupt d/c anti-seizure drug brain tumor/trauma systemic or cns infection etoh withdrawl drug overdose
tonic v clonic
tonic- stiff
clonic- jerking
general anti-epileptic drugs (AEDs)- moa, therap effect
control act but do not cure disorder
moa- dec mvmnt ions into nerve cells (block na= dec excitability and inc stability of cells (higher seiz. threshold))
inc act. neurotrans (gaba- dec excitability)
aed- phenotoyin- indications, routes
indications- prevent/trt seziures, bipolar, neuropathic pain
routes- oral/ng- dec absorption w/ tube feeds (stop feed 1h b4 and 1h after, can dec absorb by 70%)- can lead to malnutrition
IV- lots d-d interactions, only compatible w/ ns (have to piggyb)
assess iv site before admin (can cause phlebitis)
no IM- poor absorb
aed- phenytoin- therap range and role of protein
protein bound (ng interaction), only unbound drug is active (protein or malnourished ppl need dec dose bc less drug is taken out of circulation)
5-20mcg/ml or 0.8-2.0 mcg/ml unbound
checked after start of therapy
aed- phenytoin- d-d interactions
enzyme inducer- inc activity of metab enzymes
inc metab drugs= inc rate inactive form= dec effect bc shorter half life
aed phenytoin- ae and rare rxns
ae- ataxia, nystagmus, diplopia, n/v w/ po, hypotension
serious- allergic rxn (dress, sjs, angioedema)
dress- skin rash + muc. mem.
sjs- skin peeling
hepatic failure (LFTs)
bone marrow depression (agranulocy, aplastic anemia)
cardiac arrest (suppress elect act of heart)
suicidal thoughts
aed phenytoin- s/s toxicity
dizziness, nystagmus, slurred speech, aphasia, confusion, ataxia
aed- phenytoin- contraindications/ cautions
hypersen (angioedema and epith dis) preg (terratogenic) heart block (dec conduction= dec hr) cns depression hepatic impairment 15:02 allele (assoc. w/ epith hypersen rxns)
aed- treats what type seizures
generalized seizures (tonic clonic or absence)
aed- fosphenytoin (cerebyx)
safer IV version phenyotin (less irritation and d-d rxns than phenytoin)
converted to phenytoin after IV injection (prodrug)
activated after liver metab
aed- carbamazepine (tegretol)
narrow therapeutic range (high risk toxicity)
black box warning- aplastic anemia and agranulocytosis (bone marrow dec)
assoc. w/ 15:02 allele disposition
aed- valpronic acid (depakote)
highest risk birth defects (avoid in women pregnant or planning to be)
aed- diazepam (valium), lorazepam (ativan)
pams
benzodiazepines
shorter acting
physical dependence w/ chronic admin (lead to w/drawl s/s)
aed-clonazepam (klonipin)- benzodiazepines
longer acting
inc gaba act
taper if long term use to avoid s/s withdrawl
aed- phenobarbital
long half life
3-4wks to reach steady state
can cause cns depression
aed- partial seizure- gabapentin or pregabalin- def and ae
trt neuropathic pain
half life inc w/ dec renal fun
ae- dizziness, drowsy, fatigue, tremor, n/v (dec overtime)
1st dose given at bedtime d/t dizziness
aed- partial seizure- lemotrigine-ae
dizzy, drowsy, ataxia, blurred vision, n/v, headachd
adjunct med
aed- partial seizure- levetiracetam (keppra)
used in combo therapy
less d-d interactions w/ o/ aed
*not metab in liver
aed- general assessment
hx seiz/drugs
monitor serum drug lvls (esp tegretol)
describe seizure
what to document- seizure
characteristics duration loss consciousness loss bowel/bladder control post-seizure beh